A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing.
A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing.
复制标题
DOI:
10.1016/j.vaccine.2012.12.077
复制
发表时间:
2013-04-08
期刊:
影响因子:
5.5
通讯作者:
Petrovsky, Nikolai
中科院分区:
文献类型:
--
作者:
Saade, Fadi;Honda-Okubo, Yoshikazu;Trec, Samay;Petrovsky, Nikolai
Although current HBV vaccines have an outstanding record of safety and efficacy, reduced immunogenicity is a problem in those of older age, or having renal impairment or diabetes mellitus. In this study, we tested the ability of Advax™ adjuvant, a novel polysaccharide adjuvant based on delta inulin, to enhance the immunogenicity of hepatitis B surface antigen (HBs) in mice and guinea pigs by comparison to the traditional alum adjuvant. Advax™ provided antigen-sparing and significantly enhanced both anti-HBs antibody titers and anti-HBs CD4 and CD8 T-cells, with increases in Th1, Th2 and Th17 cytokine responses. Unlike alum, the adjuvant effect of Advax™ was seen even when injected 24 hours before the HBs antigen. Advax™ adjuvant similarly enhanced humoral and cellular immune responses in guinea pigs to a third generation preS-HBs antigen. Inclusion Advax™ adjuvant when combined with HBs antigen could provide enhanced protection over current generation HBV vaccines for immunization of low responder populations.
登录
查看更多内容
影响因子:
5.5
作者:
Gordon DL;Sajkov D;Woodman RJ;Honda-Okubo Y;Cox MM;Heinzel S;Petrovsky N
通讯作者:
Petrovsky N
影响因子:
15.9
作者:
GRANOFF, DM;SHACKELFORD, PG;MESCHIEVITZ, CK
通讯作者:
MESCHIEVITZ, CK
影响因子:
5.5
作者:
Halperin, Scott A.;Ward, Brian;Martin, J. Tyler
通讯作者:
Martin, J. Tyler
影响因子:
5.5
作者:
Halperin, SA;Dobson, S;Eiden, JJ
通讯作者:
Eiden, JJ
影响因子:
9.1
作者:
Cooper, CL;Davis, HL;Heathcote, J
通讯作者:
Heathcote, J